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conformation of N-terminal outside-C-terminal outside and loop inside. There are four Higd genes, Higd-1a,
-1b, -1c and -2a, in the mouse. Higd-1a and -2a are expressed primarily in the brain, heart, kidney and
leukocytes. HIF (hypoxia-inducible factor) overexpression induced the endogenous expression and promoter
activity of Higd-1a. Mutation of the HRE (hypoxia-response element) site at−32 bp in the Higd-1a promoter
reduced the promoter activity, suggesting that transcription of Higd-1a is regulated by binding of the
transcription factor HIF to the HRE. Higd-1a promoted cell survival under hypoxia. RAW264.7 cells stably
transfected with Higd-1a underwent less apoptosis than control cells in a hypoxic condition, and hypoxia-
induced apoptosis was strongly enhanced when endogenous Higd-1a was silenced by siRNA. The survival
effect of Higd-1awas completely abolished by deletion of the 26 N-terminal amino acids, and we showed that
Higd-1a increased survival by inhibiting cytochrome C release and reducing the activities of caspases.
However, expression of Bcl-2, Bax, Bad, and BNIP3 and translocation of AIF were unaffected under the same
conditions. Higd-2a also enhanced cell survival under hypoxia. Cells transfected with Higd-2a underwent less
apoptosis than control cells in hypoxic conditions, and hypoxia-induced apoptosis increased when
endogenous Higd-2a was depleted. Together these observations indicate that Higd-1a is induced by hypoxia
in a HIF-dependent manner and its anti-apoptotic effect results from inhibiting cytochrome C release and
reducing caspase activities.amily; NO, nitric oxide; BNIP3,
-1, hypoxia-inducible factor-1;
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Maintaining a stable oxygen level is a requirement of most forms
of life. Hence, hypoxia induces adaptive physiological responses such
as increased glucose uptake and a switch from oxidative phosphor-
ylation to anaerobic glycolysis [1]. To improve oxygenation, the
expression of proteins responsible for angiogenesis, erythropoiesis,
iron metabolism and proliferation is induced in hypoxic cells [2–5].
However, if the hypoxic challenge is extreme or prolonged it also
induces cell death, thus preventing the accumulation of altered or
mutated cells [6]. From the point of view of pathology, hypoxia is
related withmalignant tumors and cardiac diseases [7,8]. Since cancer
cells that circumvent hypoxic cell death are more resistant toenvironmental stresses, hypoxia is regarded as one of the factors
affecting the aggressiveness of cancers and their resistance to treat-
ment, and therefore overall patient survival.
One of the main signaling pathways in hypoxia is activation of the
transcription factor, HIF-1 (hypoxia inducible factor-1) [9,10]. HIF-1 is a
heterodimer of hypoxia-inducible HIF-1α and constitutively expressed
HIF-1β/ARNT (aryl hydrocarbon receptor nuclear translocator). Under
normoxic conditions, HIF-1α undergoes proline hydroxylation, binds
to VHL (Von Hippel Lindau protein) and is ultimately broken down
after ubiquitination [11]. In hypoxic conditions it is not hydroxylated
but binds to HIF-1β/ARNT and is translocated to the nucleus where it
accumulates and activates transcription of target genes via HREs
(hypoxia-response elements). HIF-2α, an isomer of HIF-1α, also plays
important roles in downstream signaling of hypoxia [12]. It hetero-
dimerizeswithHIF-1β andbinds to the sameconservedDNA sequences,
but its tissue distribution is different from HIF-1α. Activation of HIF
induces factors necessary for increased blood supply, anaerobic ATP
generation and proliferation. Examples are: VEGF (vascular endothelial
growth factor)-A and its receptor VEGFR1/FLT1 [13], which are involved
in blood vessel formation; erythropoietin, involved in erythropoiesis
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IGF (insulin-like growth factor) 2, involved in proliferation [14]. HIF
also regulates cell death pathways by interacting with and activating
tumor suppressor p53, a factor that turns on the mitochondrial apo-
ptosis pathway by inducing Bax production, cytochrome C release
and activation of caspases 3 and 9 [15]. HIF also induces expression
of BNIP3 and BNIP3L/NIX, which mediate mitochondrial cell death via
the mitochondrial membrane permeability transition and ROS pro-
duction [16,17], although recent reports have given rise to debate re-
garding the role of BNIP3 in necrosis, apoptosis, autophagic cell death
and even survival. Collectively HIF activates many factors implicated
in various hypoxia-related pathways.
Higd-1a was previously referred to as HIMP1-a (hypoglycemia/
hypoxia inducible mitochondrial protein) [18] or just HIG1 [19–21]. It
is a 10.4 kDa mitochondrial inner membrane protein predicted to
have two transmembrane domains oriented in an “N-terminal
outside-C-terminal outside and loop inside” conformation [18]. It is
an alternatively spliced form of HIMP1-b in human, and its N-terminal
17 amino acids are speciﬁed by different nucleotides than those of
HIMP1-b. Higd-1a is induced by hypoxia and deprivation of glucose
in human cervical epithelial cells and murine cerebral cortical neu-
rons [19,20], and has been suggested to play a role in metabolic and
oxidative stress. It is also thought to promote the survival of α and
β cells of the pancreas under conditions of stress because when
overexpressed in pancreatic β cells, it increases survival in response
to hypoxia and low glucose [18]. Although it is induced by hypoxia
and promotes survival, its modes of action and induction remain to
be clariﬁed. In addition, there is no information about homologous
proteins.
RAW264.7 macrophages have been used as models of apoptosis in
response to various types of stress, including NO (nitric oxide), ROS
(reactive oxygen species) and LPS (lipopolysaccharide). We have
previously shown that under normoxic conditions macrophage
Higd-1a is induced by exogenously added NO [22] and the hypoxia-
inducible genes can be up-regulated by NO through HIF-1α in
RAW264.7 cells [23,24]. In the present investigation we addressed the
role ofHigd-1a in apoptosis induced by hypoxia.We exposed RAW264.7
macrophages stably transfected with Higd-1a and control cells to
hypoxia (1% O2) for up to six days. The Higd-1a-transfected cells
underwent signiﬁcantly less apoptosis, and this survival effect resulted
from inhibition of cytochrome C release and reduced caspase activities.
Theeffect ofHigd-1aoverexpressionwas completely abrogatedwhen its
N-terminal 26 amino acids were deleted. We also examined the
expression and induction of other Higdmembers and found that Higd-
2a also promoted cell survival in hypoxia.
2. Materials and methods
2.1. Cell culture
The RAW264.7 mouse macrophage cells were obtained from ATCC
and HeLa human cervical cancer cells and AsPC-1 human pancreatic
adenocarcinoma cells were obtained from Korea Cell Line Bank. For
hypoxia treatment, cells were grown under 1% oxygen (5% CO2 and
94% N2) in a hypoxia chamber (Billups-Rothenberg Inc., CA, USA). For
low glucose treatment, cells were maintained in DMEM containing
0.5 mM D-glucose, 0.02 mM sodium pyruvate.
2.2. Construction of expression and reporter plasmids
The total RNA of RAW264.7 cells was reverse-transcribed and
Higd-1a,-2a and Higd-1a-ΔNT (27–95 amino acids) were ampliﬁed by
PCR and cloned into pcDNA3.1/V5-His A (Invitrogen) or pBICEP-CMV-2
(Invitrogen). The putative mouse Higd-1a and -2a promoter frag-
ments were ampliﬁed with primers and mouse genomic DNA as
template. The ampliﬁed DNA fragments were cloned upstream ofluc+ in pGL3 Basic vector (Promega). The putative Higd-1a promoter
sequence was searched for transcription factor-binding sites with
the MatInspector program (Genomatrix Software GmbH). Altera-
tion of HRE from CACGT to CAACA (−36 to −32 bp) in the Higd-1a
promoter was performed as described previously [23]. Vectors ex-
pressing HIF-1α and -2αwere kind gifts of Dr. Jong-Wan Park (Seoul
National University, Seoul, Korea) [25,26].
2.3. Preparation of stably transfected cell lines
RAW264.7 cells were transfected with mock vector, the Higd-1a
and Higd-1a-ΔNT constructs. After two days, cells were exposed to
selection with 2 mg/ml G-418 (Duchefa Biochemie). After one week
they were sub-cultured onto 96-well plates to select colonies. After
colonies had been established from single cell, the cells were frozen
and stored in liquid nitrogen and a fresh aliquot of cells was used for
each set of experiments.
2.4. Transient transfections and Dual-Luciferase assays
Transfections were performed with Transfectin™ lipid reagent
(Bio-Rad). They were transfected with 2 μg of reporter plasmids and
0.3 μg of pRL-TK (an internal control plasmid expressing the Renilla
luciferase gene; Promega). Fireﬂy and Renilla luciferase activities in
cell lysates were measured sequentially using a Dual-Luciferase re-
porter assay system (Promega) with a VICTOR3 multilabel reader
(Perkin Elmer Life Sciences).
2.5. Flow cytometric analysis
Propidium iodide staining of apoptotic cells was performed as
described previously [23]. For cell cycle analysis, 1×106 cells were
ﬁxed by drop-wise addition to 70% ice-cold ethanol and overnight
incubation at 4 °C. The cell pellet was then resuspended in 0.2 ml PBS
containing 50 μg/ml of propidium iodide (Molecular Probes) and
0.1 μg/ml of RNase A (Sigma). After at least 30 min incubation at room
temperature, the cells were acquired with a FACScan cytometer. For
nonyl acridine orange (NAO) staining (Molecular Probes), cells were
resuspended in PBS at 1×106 cells/ml, incubated with 1 nM NAO for
10 min at room temperature in the dark and analyzed with a FACScan
[27]. Data were analyzed with ModFit LT Version 3.0 software.
2.6. Immunoblotting analysis
Cultured cells were lysed in lysis buffer (1 mM Tris, 5 mM NaCl,
0.5 mM EDTA, 10% NP-40, 100 mM PMSF). The cell lysate was incu-
bated on ice for 15 min and cleared by centrifugation. Samples of
protein were resolved on SDS-PAGE and transferred to a polyvinyli-
dene diﬂuoride membrane (Millipore, Bedford, MA) in aMighty Small
Transphor unit (Amersham Biosciences). Anti-Bax (sc-493), anti-Bad
(H-168) and anti-Bcl-2 (sc-783) were purchased from Santa Cruz
Biotechnology, (USA); anti-BNIP3 (ab10433) was from Abcam plc.
(UK) and anti-β-actin monoclonal antibody (A5060) was from Sigma-
Aldrich (USA). To obtain the mitochondrial fraction, cells were
harvested, washed and prepared using a Mitochondria isolation kit
(Pierce), following the manufacturer's instructions. Anti-Hsp60
(611562) and anti-cytochrome c (556433) were purchased from BD
Pharmingen™; anti-α-tubulin (T5168) was from Sigma and anti-AIF
(sc-13116) from Santa Cruz. Antibody against the N-terminal 9–21
residues of human Higd-1a was raised in rabbits and used after
puriﬁcation through protein A agarose column.
2.7. Intracellular immunostaining
RAW264.7 cells were grown on coverslips in 6-well plates, washed
with PBS and stained with MitoTracker dyes (Invitrogen, M7512). The
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permeabilized in 0.5% TritonX-100 for 15 min at room temperature. The
cells were incubated with anti-V5 antibodies (Invitrogen, R960-25)
(1:200), anti-cytochrome C (Santa Cruz, sc-13561) (1:200) for 3 h at
4 °C. Theywere thenwashedand incubatedwithﬂuorescein-conjugated
goat anti-mouse IgG (Invitrogen, F2761) (1:200) as secondary antibody
along with 5 μg/ml Hoechst 33258 (Sigma-Aldrich) for 30 min at room
temperature. Fluorescent images were acquired with a Zeiss confocal
microscope (Carl Zeiss).
2.8. Caspase activity assays
Caspase 3 activities were measured with a Florescent Assay Kit
(Peptron, SouthKorea). Caspase 9wasmeasuredwith a Caspase-Glo® 9
Assay Kit (Promega). Caspase activities in cell lysates were measured
with a VICTOR3 multilabel reader.
2.9. RNA interference and RT-PCR Analysis
Total RNA was reverse transcribed with M-MLV Reverse Tran-
scriptase (Promega, Madison, WI, USA), and semi-quantitative PCR
was performed with the following primer pairs: mouse Higd-1a
forward 5′-ATGTCAACCAACACAGACC-3′, reverse 5′-TAGGCTTAGGCT-
TAGGGTTG-3′; Higd-1b forward 5′-ATGTCTGCTAACAAGGGCTG-3′,
reverse 5′-CTTCTCGGCATCCTCTGACA-3′;Higd-1c forward5′-ATGTCTT-
CAGATGAGTGGTCAG-3′, reverse 5′-GAAGTTACATGGGTTTTTCATT-3′;
Higd-2a forward 5′-ATGGCGGCTCCCGGTCCTGT-3′, reverse 5′-GGCTTGA-
GACTTCATAGCAG-3′; β-actin forward 5′-GTGGGGCGCCCCAGGCACCA-
3′, reverse5′-CTCCTTAATGTCACGCACGATTTC-3′;mouseHIF-1α forward
5′-AGCCCTAGATGGCTTTGTGA-3′, reverse 5′-TATCGAGGCTGTGTC-
GACTG-3′. PCR products were resolved by electrophoresis on 1%
agarose gels and ethidium bromide staining. All reactions were
performed in duplicate. Quantitative real-time PCR was performed
with a Rotor Gene 2000 (Cobett Research, Syden, Australia) and a
SYBR Green I reaction (Qiagen, Hilden, Germany) according to the
manufacturer's instructions. Scramble control small interfering RNA
(siRNA) targeting the sequence; 5-CCUACGCCACCAAUUUCGU-3′
(sense) and 5′-ACGAAAUUGGUGGCGUAGG-3′ (antisense), mouse
HIF-1α siRNA targeting the sequence (#1368760); 5′-GUGGUUGG-
GUCUAACACUA-3′ (sense) and 5′-UAGUGUUAGACCCAACCAC-3′
(antisense). Human Higd-1a siRNA targeting the sequence
(#1171250); 5′-GACCGAAUUACU AGUGACU-3′ (sense) and 5′-AGU-
CACUAGUAAUUCGGUC-3′ (antisense), Higd-2a siRNA targeting the
sequence (#1068482); 5′-CUUGAAAGCUCCGCAGAAA-3′ (sense) and
5′-UUUCUGCGGAGCUUUCAAG-3′ (antisense).
2.10. Quantiﬁcation of mtDNA by PCR
Relative mitochondrial DNA content was evaluated as previously
described by Parone et al. [28]. Brieﬂy, total DNA was obtained by
resuspending cells in extraction solution (0.2 mg/ml proteinase K, 0.2%
SDS and 5 mMEDTA in PBS) and precipitating it with isopropanol. PCR
ampliﬁcation was performed with the following primer pairs; mtDNA
12S RNA gene: forward 5′-GCTCGCCAGAACACTACGAG-3′, reverse 5′-
CAGGGTTTGCTGAAGATGGCG-3′; elongation translation factor 1 gene
(EEF1A1): forward 5′-GGATTGCCACACGGCTCACATT-3′, reverse 5′-GG
TGGATAGTCTGAGAAGCTCTC-3′.
2.11. Assay of cell viability
MTT assays were performed as described previously [24]. Brieﬂy,
50 μl of MTT (3-[4,5-dimthylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide, 1 mg/ml) was included in each plate during the last 4 h of
incubation. The formazan produced by the viable cells was dissolved
in dimethyl sulfoxide and its absorbance wasmeasured at 540 nm. Forclonogenic assays, cultured cells were rinsed with PBS and visualized
with 0.02% crystal violet in 50% methanol solution.
2.12. Statistical analyses
Data are means±standard deviations (SD) of at least three inde-
pendent experiments. Statistical signiﬁcance was analyzed with Graph-
Pad Prism software version 5.01 for Windows (GraphPad Software, San
Diego, CA). p values ofb0.05 were considered signiﬁcant.
3. Results
3.1. Expression and induction of four Higd members in the mouse
In previous work BLAST search identiﬁed more than 70 homo-
logues of Higd-1a in 12 eukaryotic species [18]. In the present work
we focused on Higd members in the mouse, and queried the protein
sequence of mouse Higd-1a to the server. Three Higd-1a homologues
were identiﬁed: Higd-1b (NM_080846), Higd-1c (NM_001002900)
and Higd-2a (NM_025933) with 40–70% homology to Higd-1a,
(Fig. 1A). Like Higd-1a, they have two predicted transmembrane do-
mains, with the conserved amino acids mainly located in the trans-
membrane domains. AlthoughHigd-2a has a longer N-terminal region
thanHigd-1a, the conserved amino acids of theHigd-1aN-terminus are
also well conserved in Higd-2a. We quantiﬁed the expression of Higd
members by real-time PCR in various major tissues of the mouse.
Higd-1a mRNA was mainly expressed in the brain, heart and kidney,
andHigd-2a in the kidney, leukocytes andheart (Fig. 1B). In themouse,
Higd-1a and -2a are the members that predominate in the tissues
examined, Higd-1b and -1c being present at about one tenth the level
of Higd-1a and -2a. We also examined the induction of the four Higd
members in response to various stimuli in murine RAW264.7 macro-
phages, which have been used to study the functional roles of genes
induced by NO and HIF [23,24]. Basal expression of Higd-1a and Higd-
2a in macrophages was low. However, consistent with the previous
report [18], expression of Higd-1a was strongly induced by hypoxia
(1% O2) and low glucose (0.5 mM glucose), reaching a maximum after
6 h (Fig. 1C). Higd-2a was induced over a similar time scale but to a
lesser extent than Higd-1a. Basal expression of Higd-1b and -1c in
macrophages was very low, and hypoxia and low glucose had little
effect (data not shown). The hypoxia-induced expression of Higd-1a
protein was also examined by immunoblotting using a polyclonal
anti-Higd-1a antibody produced against the N-terminal region of
Higd-1a (Fig. 1D).
3.2. Higd-1a is induced in a HIF-dependent manner
We asked whether the induction of transcripts of Higd-1a was
dependent on binding of HIF to the Higd-1a promoter. Using PCR, we
isolated a fragment of RAW264.7 genomic DNA covering −418 bp
upstream and +173 bp downstream of the transcription start site
of mouse Higd-1a, and cloned it as a luciferase reporter construct
(Fig. 2A). In parallel, the mouse Higd-2a promoter region between
−594 bp upstream and +1 of the transcription start site was also
isolated. Each of the cloned promoter constructs contained potential
HRE sites. The Higd-1a construct had strong promoter activity in
response to SNAP (an NO donor), hypoxia, CoCl2 and DFO (Fig. 2B).
CoCl2 and DFO are hypoxia-mimetic and have previously been
shown to inhibit prolyl hydroxylase activity and stabilize HIF. The
induction by NO is consistent with our previous ﬁnding that some
HIF-dependent transcripts including Higd-1a mRNA are induced by
NO [22]. Low glucose induced only moderate transcriptional activity
and peroxide gave no signiﬁcant induction. The Higd-2a promoter
was also activated by hypoxia, CoCl2 and DFO, to a slightly lower
extent than the Higd-1a promoter, consistent with the results in
Fig. 1C. To locate the cis-acting elements in the Higd-1a promoter
Higd-1a - - - - - M S T N T D L S L S S Y - - - - - - - - - - - - - - D E G Q G S K F 20
Higd-1b - - - - - M S A N K G W W V P P E - - - - - - - - - - - - - G E D N L S K K F 21
Higd-1c - - - - - M S S D E - - W S A A E - - - - - - - - - - - - - D E G Q L S R L 18
Higd-2a M A A P G P V S P E A P F D P S K P P V I E G F S P T V Y S N P E G F K E K F 39
Higd-1a I R K A K E T P F V P I G M A G F A A I V A Y G L Y K L K S R G N T K M S I H 59
Higd-1b L R K T R E S P L V P I G V A G C L V I A A Y R I Y R L K A R G S T K L S I H 60
Higd-1c L R K S R D S P F V P V G M A G F V A V L S Y G L Y K L N S R R E Q K M S L H 57
Higd-2a I R K T R E N P M V P I G C L G T A A A L T Y G L Y C F H - R G Q S H R S Q L 77
Higd-1a L I H M R V A A Q G F V V G A M T L G M G Y S M Y Q E F W A - - - N P K P K P 95
Higd-1b L I H T R V A A Q A C A V G A I M L G A M Y T M Y R D Y I K - R V S E D A E K 98
Higd-1c L I H V R V A A Q G C V V G A V T L G V L Y S M Y K D Y I R P R F F N V P K K 96
Higd-2a M M R T R I A A Q G F T V V A I L L G L A A S A M K S Q A - - - - - - - - - - 106
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indicating that Higd-1a expression was controlled by that HRE.Next, we examined whether promoter activity and endogenous
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three independent experiments. *; Pb0.05 and ***; Pb0.001.
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abrogated the induced luciferase expression (Higd-1a P3 construct),
indicating that the HRE site at this site is responsible for induc-
tion of the Higd-1a promoter activities in response to both hypoxia
and ectopic expression of HIF. HIF-1α and -2α also increased the
endogenous expression of Higd-1a transcripts (Fig. 2E), although, in
contrast to the results in Fig. 2D, HIF-2α cotransfection was only half
as effective as cotransfection of HIF-1α. Nonetheless, these results
indicate that Higd-1a expression is controlled by the HRE located at
bp −32 and is HIF-dependent. We were also able to show that si-
lencing of HIF-1αwith siRNA inhibited hypoxia induced expression of
Higd-1a (Fig. 2F).3.3. Overexpression of Higd-1a increases cell survival in response to
hypoxia, and the N-terminal 26 amino acid region of Higd-1a is needed
for the survival effect
We next examined the role of Higd-1a. First, we generated
RAW264.7 macrophages stably transfected with Higd-1a (RAWHigd-1a).
The C-terminus of Higd-1a was tagged with the V5 antigen for easy
detection. Stable transfection and correct localization of Higd-1a were
veriﬁed by RT-PCR and intracellular staining with anti-V5 antibody,
respectively (Fig. 3A and B). The transfectants were maintained below
70% conﬂuence for six days of exposure to hypoxia by sub-culturing
every two days into hypoxia-conditioned medium. In cells transfected
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by hypoxia within a day and declined to basal level after 2 days. In the
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Fig. 3. Cell survival in hypoxia is induced by overexpression of Higd-1a. (A) Veriﬁcation of
RAWHigd-1a and RAWHigd-1a-ΔNT cells were cultured in hypoxia for the indicated time peri
indicated, by semi-quantitative RT-PCR with β-actin as an internal standard. (B) Mitochond
cultured on cover glasses and analyzed by intracellular immunostaining. The last column of
staining. (C) Four independent clonal lines each of RAWMock, RAWHigd-1a and RAWHigd-1
cell viability. Total viable cells were counted by trypan blue exclusion. Percentages of viable
***; Pb0.001. (D) Stably transfected RAWMock and RAWHigd-1a, RAWHigd-1a-ΔNT cells were cul
0.02% crystal violet.period (Fig. 3A). When the RAWHigd-1a cells were reacted with anti-V5-
FITC the staining co-localized with mitotracker, conﬁrming previous
reports that Higd-1a is in the mitochondrial inner membrane [18]Mitotracker egreM
Hypoxia
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the overexpression of Higd-1a in stably transfected cells. Stably transfected RAWMock,
ods. Total RNA was analyzed for Higd-1a or Higd-1a-ΔNT (27–95 a.a.) expression, as
rial localization of Higd-1a in stably transfected cells. The stably transfected cells were
the micrographs consists of merged images of Hoechst 33258, Anti-V5 and mitotracker
a-ΔNT were cultured under hypoxia for the indicated time periods and analyzed for
cells are shown relative to the corresponding transfected strains cultured in normoxia.
tured under hypoxia for 6 days and washed with PBS. Viable cells were visualized with
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survival of macrophages we exposed four independent clones of
RAWMock and of RAWHigd-1a to hypoxia for six days. The viable cells
were counted by trypan blue exclusion. The viability of the RAWMock
cells fell gradually over the six days to 67% of its initial level, whereas
the viability of the RAWHigd-1a cells was unaffected (Fig. 3C). We also
assessed the survival effect of Higd-1a overexpression using clonogenic
and MTT assays. We consistently stained more surviving RAWHigd-1a
cells than RAWMock cells with crystal violet after 6 days of hypoxia
(Fig. 3D) and the same result was obtained in the MTT assays (93±2.5
vs. 62±1.7%, data not shown).
We also made a mutant form of Higd-1a, designated Higd-1a-ΔNT,
with the N-terminal 26 amino acids deleted. We did not alter the
transmembrane domain because deleting it would disrupt the entire
topology of the protein. Higd-1a-ΔNT was also tagged with the V5
antigen at its C-terminus. The N-terminal deletion did not alter the
localization of the protein since it co-localized with mitotracker, like
wild type Higd-1a-V5 (Fig. 3B). However the four independent clones
of RAWHigd-1a-ΔNT cells proved to be as sensitive to hypoxia as the
RAWMock cells (Fig. 3C). These observations demonstrate that the
N-terminal region of Higd-1a, located in the inter-membrane space of
mitochondria, is required for the survival effect.Hypoxia
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Fig. 4. Inhibition of cell death by Higd-1a overexpression. (A) RAWMock and RAWHigd-1a cel
stained with propidium iodide and analyzed by ﬂow cytometry. (B) Cells were cultured un
confocal ﬂuorescence microscopy for Hoechst staining of chromatin and differential interfer
(C) Cells were cultured under normoxia or hypoxia for 4 days and cell cycle analysis was
proportions of G0/G1, S and G2 population. This experiment was repeated three times (D)
extracts were immunoblotted with anti-Bcl-2, anti-Bax, anti-BNIP3 and anti-Bad antibod
expression. This experiment was repeated three times.To see whether the enhanced viability resulting from Higd-1a
overexpression was due to inhibition of cell death or increased pro-
liferation, RAWMock and RAWHigd-1a cells were treated with hypoxia
for six days and harvested at the indicated times. First, cells were
stained with propidium iodide and analyzed by ﬂow cytometry. The
number of propidium iodide-positive cells increased greatly after
4 days of hypoxia in RAWMock but not in RAWHigd-1a (Fig. 4A). When
cell nuclei were stained with Hoechst 33258 after 4 days of hypoxia
and observed with a confocal microscope, the RAWMock cells showed
apoptotic changes, whereas the RAWHigd-1a cells showed only
background levels of apoptotic cells (Fig. 4B). When we performed a
cell cycle analysis of the treated cells by ﬂow cytometry, gating only
live cells, we noted only a small increase in G0/G1 arrest in both types
of transfected cell. After 4 days of hypoxia, the fractions of G0/G1 cells
increased from 52% to 57% and from 46% to 48% for the RAWMock and
RAWHigd-1a cells, respectively (Fig. 4C). However, these changes were
negligible compared to the extent of cell death in Fig. 4A and dem-
onstrate that hypoxiamainly leads to apoptosis in RAW264.7 cells and
that the over-expression of Higd-1a reduces this effect, rather than
increasing cell multiplication.
Hypoxia-induced apoptosis has been reported to be associated
with induction of Bax and BNIP3 [6]. Therefore we characterized theB Hoechst DIC Merge
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hypoxia treatment. Expression of the Bcl-2 family proteins did not differ
markedly between the RAWMock and the RAWHigd-1a cells (Fig. 4D). In
both cases, Bcl-2 expression was strongly induced and peaked within
two days. This kinetics appears consistent with the loss of viability of
RAWMock cells, in which apoptosis starts to occur between 2 and 4 days
(Fig. 3C). Bax was also induced after two days and remained high until
day four in both cases. Expression of BNIP3 and Bad increased slightly
but was not signiﬁcantly affected by hypoxia. These ﬁndings demon-
strate that the survival effect of Higd-1a does not depend upon dif-
ferential regulation of Bcl-2 family members such as Bcl-2, Bax, BNIP3
and Bad.
3.4. The survival effect of Higd-1a involves inhibition of cytochrome C
release and reduction of caspase activity
It has been reported that hypoxia-induced apoptosis involving
activation of caspase 9 can occur in either a cytochrome C-dependent
or -independent manner [6]. Because Higd-1a is a mitochondrial
membrane protein, we examined its role in cytochrome C release,
caspase activation and translocation of AIF (apoptosis inducing factor).
RAWMock, RAWHigd-1a and RAWHigd-1a-ΔNT cells were cultured under
hypoxia for 4 days, harvested and stained with anti-cytochrome CA
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Fig. 5. Inhibition of cytochrome C release into the cytosol during hypoxia by Higd-1a overex
for 4 days. The cells were harvested and stainedwith anti-cytochrome C and Hoechst 33258
RAW264.7 cells were cultured in the presence of 200 μM etoposide for 48 h. (B) Cells w
prepared. 4 μg protein of each fraction was immunoblotted with anti-cytochrome C, ant
protein and α-tubulin for cytoplasmic protein. C, cytosol and M, mitochondria. (C) Inhib
RAWMock, RAWHigd-1a and RAWHigd-1a-ΔNT cells were exposed to hypoxia for the indicat
Ac-DEVD-AMC (caspase 3) and Z-LEHD-aminoluciferin (caspase 9), and normalized by
corresponding transfected cells in normoxia. (D) Cells were exposed to hypoxia for the i
inhibitor). Total viable cells were counted by trypan blue exclusion. Percentages of viable
Data are the means±S.E.. **; Pb0.01, ***; Pb0.001.antibody. In the RAWMock and RAWHigd-1a-ΔNT cells, but not in the
RAWHigd-1a cells, cytochrome C was clearly released into the
cytoplasm (Fig. 5A). Since several thorough washes with PBS were
neededprior to intracellular staining, the apoptotic cells in theRAWMock
and RAWHigd-1a-ΔNT cultures were lost, and there were fewer cells
under the ﬂuorescence microscope. A positive control experiment
with etoposide generated the typical morphology of cytochrome C
release from mitochondria, thus clearly conﬁrming the inhibition
of cytochrome C release in RAWHigd-1a cells. To conﬁrm these obser-
vations, we performed an immunoblot analysis after fractionating the
cells into mitochondrial and cytosolic fractions. In agreement with the
results in Fig. 5A, four days of hypoxia led to the release of cytochromeC
from themitochondria of the RAWMock and RAWHigd-1a-ΔNT cells but not
from those of the RAWHigd-1a cells (Fig. 5B). On the other hand, AIF
was not released by hypoxia from the mitochondria of any of these
cells. To see whether hypoxia and overexpression ofHigd-1a affected
the activation of caspases, stably transfected cells were cultured in
hypoxia for 6 days and examined at the indicated times. In the
RAWMock and RAWHigd-1a-ΔNT cells, caspase 3 activities increased
after 4 days and were sustained until the sixth day (Fig. 5C). The
RAWHigd-1a cells contained less caspase 3 activity than the RAWMock
cells (2.6 vs. 8.1 fold increase on day 4; 3.5 vs. 8.8 fold, on day six), and
caspase 9 activities paralleled those of caspase 3. Caspase 9 activityRAWHigd-1a- NT B
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whereas it increased considerably less in the RAWHigd-1a cells (3.5 vs.
18 fold). To conﬁrm that the caspase 9 activation during hypoxia was
related to cell death, stably transfected cells were exposed to hypoxia
in the presence of a caspase 9 inhibitor. This signiﬁcantly reduced
apoptosis in the RAWMock and RAWHigd-1a-ΔNT cells (Fig. 5D).
Although the overlapping cleavage speciﬁcity of the caspase sub-
strates should be considered, we could, at least, show that caspase
activities were regulated by Higd-1a using the substrates and an
inhibitor of caspases. These results demonstrate that inhibition of
cytochrome C release and reduced activation of caspases are involved
in the survival effect of Higd-1a under hypoxic conditions.
3.5. Survival effect of Higd-2a in response to hypoxia
MouseHigd-1a and -2a share homology of 46% and their identity is
even higher in the transmembrane domain and C-terminal half of the
N-terminal region. Therefore, we next compared the survival effects ofScramb
Higd-1
Higd-2
B
Pr
op
or
tio
n 
of
 v
ia
bl
e 
ce
lls
 (%
)
0
20
40
60
80
100
120
AsPC-1 HeLa
N
*
*
*
*
*
H
*
*
*
*
*
H
*
*
*
*
*
*
N
*
*
*
*
*
A
Pr
op
or
tio
n 
of
 v
ia
bl
e 
ce
lls
 (%
) Mock
Higd-1a
Higd-2a
0
20
40
60
80
100
120
Hypoxia 
***
anti-flag
0 36 48  (hr)
*
mtDNA 
C D
20
0
100 101              102              103
Log fluorescence intensity 
(FL1-H)
0
Co
un
ts
Scrambled siRNA
Higd-1a siRNA
Fig. 6. Cell survival in hypoxia is promoted by overexpression of Higd-2a. (A) RAW264.7 cells
and cultured in hypoxia for the indicated time periods. 5 μg of total cell extracts was imm
exclusion. (B) AsPC-1 and HeLa cells were transiently transfected with siRNA against human
scrambled siRNA was used. Total RNA of each of the transfected cultures was analyzed for t
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transfected with scrambled siRNA or human Higd-1a siRNA and cultured in normoxia fo
mitochondrial gene (Left) and by quantitative real-time PCR (Right). The EEF1A1 (elongati
times.Higd-1a and -2a. The N-termini of Higd-1a and -2a were tagged with
ﬂag antigen for easy detection. Transient transfection of the
expression constructs and ectopic expression of Higd-1a and -2a
was veriﬁed by immunoblot (Fig. 6A). The viability of the mock- and
Higd-1a-transfected cells decreased gradually over two days of
hypoxia. As expected, the Higd-1a-transfected cells survived better
than the mock-transfected cells (34 vs. 59% at 48 h). The Higd-2a-
transfected cells also were 52% viable after 48 h of hypoxia indicating
that Higd-2a affects survival about as much as Higd-1a. Apoptosis in
the transiently transfected cells was in general higher than in the
stably transfected cells of Fig. 3C, probably because the lipid reagent
used in transfection also affects cell viability, and the efﬁciency of
transient transfection was less than 50%.
To address the effect of silencing of Higd-1a and -2a expression we
used AsPC-1 pancreatic adenoma and HeLa cells because their basal
expression of Higd-1a and -2a is much higher than that of RAW264.7
macrophages. Silencing of Higd-1a and -2a in these cell lines was
conﬁrmed by RT-PCR analysis (Fig. 6B, right panel). Expression fell byled siRNA
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were transiently transfected with expression vectors forHigd-1a and -2a tagged by ﬂag,
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Higd-1a and -2a and cultured in normoxia (N) and hypoxia (H) for 3 days. As a control,
he expression of Higd-1a and -2a by semi-quantitative RT-PCR. β-Actin was used as an
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r 3 days. Total DNA was analyzed by PCR for the 12S ribosomal RNA small subunit
on translation factor 1) gene served as a control. This experiment was repeated three
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6 days (data not shown). Interestingly, silencing of Higd-1a reduced
cell viability in normoxia, compared with the levels in control cells
transfected with scrambled siRNA. It was 60% of control cells in
AsPC-1 and 58% in HeLa (Fig. 6B, left panel). Silencing of Higd-1a
further reduced cell viability in hypoxia. There were only about 8%
viable cells in Higd-1a-silenced AsPC-1 cells after 3 days of hypoxia.
Silencing of Higd-2a in AsPC-1 and HeLa cells also reduced viability.
Although the effect was a little less than with Higd-1a, the extent may
depend on the cell line, the level of basal expression and the efﬁciency
of silencing. Our results show that both Higd-1a and -2a have survival
effects in a variety of cell lines.
Since Higd-1a is a mitochondrial inner membrane protein, we
examined whether silencing of Higd-1a led to a change of mitochon-
drial mass or DNA content. Flow cytometric analysis using nonyl
acridine orange (NAO) indeed revealed a reduction in the mitochon-
drial mass of the Higd-1a-silenced cells (Fig. 6C); furthermore
quantitative PCR ampliﬁcation showed that the number of copies of
the 12S ribosomal RNA small subunit mitochondrial gene was greatly
reduced relative to nuclear content, pointing to loss of mitochondrial
DNA (Fig. 6D). These results indicate that Higd-1a depletion affects
mitochondrial integrity.
4. Discussion
In this study we characterized the role of Higd-1a in hypoxia-
induced cell death in RAW264.7macrophages. The following evidence
suggests that Higd-1a has an anti-apoptotic effect in these cells:
(a) RAW264.7 cells transfected with Higd-1a (RAWHigd-1a cells)
survived better in hypoxic conditions than mock transfected cells
(Fig. 3). (b) The enhanced viability was mainly due to a reduced
number of apoptotic cells (Fig. 4). (c) The survival effect of Higd-1a
was associated with inhibition of cytochrome C release and reduced
activities of caspases (Fig. 5). These results were further veriﬁed by
showing that hypoxia-induced apoptosis in pancreatic and cervical
cancer cells was enhanced when endogenous Higd-1awas silenced by
transfection with Higd-1a siRNA (Fig. 6). Consistent with our data,
Wang et al. have shown that Higd-1a promotes survival in hypoxia
and low glucose when overexpressed in pancreatic β cells [18]. We
have now shown that the survival effect of Higd-1a is not restricted to
pancreatic cells but occurs in various cell lines as well. Our data
demonstrate that Higd-1a operates by blocking the general mito-
chondrial death pathway involving cytochrome C and caspases. Since
this pathway is critical for apoptosis in many cell types, Higd-1a may
have a widespread anti-apoptotic effect.
Bcl-2 family proteins are involved in the hypoxia-induced apoptosis
ofmacrophages.We used prolonged exposure to 1% O2 tomaximize the
difference in viability between RAWMock and RAWHigd-1a cells and to
demonstrate the anti-apoptotic effect of Higd-1a. In this situation,
RAWMock cells hardly showed any signs of apoptosis until the second
day and induction of apoptosis became obvious only between days 2
and 6 (Fig. 3C). These death kinetics were closely related to the ratio of
expression of Bcl-2 vs. Bax (Fig. 4D), in agreementwith previous reports
that inhibition of Bcl-2 during hypoxia results in endothelial apoptosis
[29], and that overexpression of Bcl-2 inhibits hypoxia-induced cell
death in several cell lines and tissues including PC12 and hepatoma cells
[30,31]. Furthermore, embryonicﬁbroblasts of Bax−/− andBak−/−mice
do not die when deprived of oxygen, and the hippocampal tissue of
Bax−/− mice contains fewer apoptotic cells and less caspase 3 activity
after hypoxia–ischemia than does the corresponding wild type tissue
[32,33]. Nevertheless, the pattern of expression of Bcl-2, Bax, Bad and
BNIP3 in RAWHigd-1a cells was quite similar to that in RAWMock cells,
showing that the anti-apoptotic effect of Higd-1a does not involve
changes in the expression of Bcl-2 family proteins.
Higd-1a is a mitochondrial inner membrane protein and its N- and
C-terminal regions are located in the intermembrane space [18].Deletion of the N-terminal region completely abolished the survival
effect of Higd-1a (Fig. 3C). It did so without altering the localization of
the protein (Fig. 3B) and is unlikely to have changed the overall
conformation of the protein because the deletion is small and the
region eliminated is predicted to form a disordered loop. This ﬁnding
demonstrates that the N-terminal region plays a critical role in the
action of Higd-1a. Several death-related soluble factors, such as
cytochrome C, AIF, endonuclease G and smac/Diablo, are located in the
intermembrane space, and this space is also the locus of interactions
between proteins such as VDAC (voltage dependent anion channel)
and ANT (adenine nucleotide translocase) [34].
Higd-1a expression has been shown to be induced by hypoxia and
low glucose in various cell types including neuronal, pancreatic and
cervical cancer cells [18–21]. We previously showed that NO
treatment enhanced the expression of Higd-1a in macrophages [22].
In the present study, we showed thatHigd-1a promoter activity can be
induced by hypoxia, NO and low glucose, and that promoter activity is
abolished by mutation of the HRE at −32 bp from the transcription
start site of Higd-1a (Fig. 2). Furthermore, cotransfection of HIF-1α or
-2α led to a signiﬁcant induction of the promoter activities and
endogenous expression of Higd-1a. Silencing of HIF-1α using siRNA
inhibited the hypoxia induced expression of Higd-1a. These results
lead to the conclusion that Higd-1a transcription is driven by HIF.
Under our experimental conditions the promoter activity of Higd-1a
P2, which has one HRE site, was 30% more active in response to
ectopic expression of HIF-2α than in response to HIF-1α (Fig. 2D)
whereas endogenous Higd-1a mRNA expression was 60% more
responsive to ectopic expression of HIF-1α than to that of HIF-2α
(Fig. 2E). To understand this difference, we tested the activity of Higd-
1a P1, whose upstream sequence extends to bp −418 and thus
contains both of the HRE sites. As shown in Fig. 2D, the activities of P1
and P2 were induced to similar extents by co-transfection with HIF-
1α or HIF-2α. Therefore, the discrepancies between the promoter
activities and the endogenous mRNA expression of Higd-1a (Fig. 2D
and E) are not due to the proximal two HRE sites but may depend on
some effect of the distal region of the promoter or some downstream
locus regulating Higd-1a expression. Future research examining other
regulatory regions may clarify this matter. Although HIF is a sensor of
oxygen and is mainly regulated by low oxygen conditions, other
factors induce it in normoxic conditions. Oncogenes such as Ras and
Src have been shown to increase HIF-1α, and growth factors such as
insulin-like growth factor, epidermal growth factor and interleukin 1
also induce it [14,35–38]. We and others have previously shown that
HIF-1α is up-regulated by NO [23,39,40]. These various ﬁndings
suggest that HIF is required for the induction of various essential
genes not only in hypoxic but also in normoxic conditions. It is likely
therefore that Higd-1a plays an important role in opposing cell death
in response to diverse stresses.
We found that expression of Higd-1a and -2a in RAW264.7
macrophages was low, but was stimulated by hypoxia or hypoxia-
mimetic conditions. Macrophages are the differentiated form of
monocytes, which circulate in the blood and extravasate into infected
tissues. Inﬂamed tissues can confront hypoxic or ischemic conditions
resulting from reduced blood vessel growth and damaged blood
supply [41]. Macrophages concentrated in inﬂamed regions have to
respond rapidly to hypoxia and express various hypoxia-inducible
genes that play roles in cellular functions such as cell survival, and
proangiogenic and proinﬂammatory responses [42–44]. Research on
the effects of hypoxia on macrophages and monocytes are important
for understanding the progression of inﬂammation and wound
healing. In addition, there is growing evidence that macrophages
are implicated in other kinds of disease such as malignant tumor
progression, atherosclerosis, and rheumatoid arthritis [45–47]. We
also examined the expression and induction pattern of the various
Higd isomers in a number of tissues, and found that murine Higd-1a
was expressed at a high level in the brain and heart, andHigd-2a in the
2098 H.-J. An et al. / Biochimica et Biophysica Acta 1813 (2011) 2088–2098kidney, leukocytes and heart. Expression of Higd-1a and 2a was
further enhanced by hypoxia and low glucose. Wang et al. have
reported that the human form of Higd-1a is present at especially high
levels in cardiomyocytes [18]. Since bothHigd-1a and -2a can enhance
cell survival, elevated expression of these Higd isomers may defend
these major organs against hypoxic and low glucose stresses. Clinical
research on the roles of the Higd isomers in ischemia, stroke and other
low oxygen conditions could lead to improvements in patient survival
rates in critical care units. Therefore, detailed mechanistic study of the
survival effect of Higd-1a and its isomers is needed to deﬁne their
roles in the hypoxic response and cellular and mitochondrial
homeostasis, and should help to develop strategies to combat
hypoxia-related diseases.
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